D
엘앤케이바이오
156100KOSDAQ의료용 기기 제조업36.5 / 100
Reference Date: 2026-04-13
Financial Score7.0 / 40
News Sentiment17.5 / 25
Momentum2.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE is below the industry average, PBR raises overvaluation concerns. Plunged 23.5% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Elan K Bio is a specialized medical device company focusing on the design, development, manufacturing, and sales of spinal implants used in orthopedic and neurosurgical procedures. Its products, classified as Class 3 medical devices, account for 95.9% of revenue generated primarily in the Americas.
Number of Employees
97people
Average Salary
60.4M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 26.524.0Point
PBR
4.40Industry Average 1.700.0Point
2.6x industry avg (risky)
ROE
-44.98Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
16.87Industry Average 10.950.5Point
1.5x industry avg (risky)
Trend 2023~20252.5 / 10 points
Revenue Growth Rate
2.5 / 3
Avg ▲14.3% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼12.7% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -14.3% (declining, 3yr)
Detailed News Sentiment
1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 70
- Positive엘앤케이바이오메드, 美클리브랜드 클리닉서 '팩투스 카데바 워크샵'...
엘앤케이바이오메드가 미국 클리브랜드 클리닉에서 '팩투스 카데바 워크샵'을 성공적으로 진행하며 흉벽기형 수술 분야 의료진의 해부학적 이해를 높였다.
Detailed Momentum
52-week position1.0Point
Near 52w low (19%, downtrend)
Current 7,610Won52-week high 15,89052-week low 5,610
1-month return0.0Point
1m -23.52% (strong drop)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-20
- Neutral정기주주총회결과2026-03-20